ISIN | CH0192306477 |
---|---|
Valor Number | 19230647 |
Bloomberg Global ID | BBG0046HFL40 |
Fund Name | Swisscanto (CH) Index Equity Fund Switzerland Total (II) GT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The investment objective of the fund is to replicate the performance of the Swiss Performance Index (SPI®). The Swiss Performance Index (SPI®) is constituted from the Swiss Exchange (SIX Swiss Exchange) and tracks the performance of Swiss companies listed on the SIX Swiss Exchange. The fund can deviate from the index.The fund assets are invested as a majority in shares and other equity securities and participation rights. |
Peculiarities |
Current Price * | 219.09 CHF | 26.08.2025 |
---|---|---|
Previous Price * | 220.01 CHF | 25.08.2025 |
52 Week High * | 225.17 CHF | 03.03.2025 |
52 Week Low * | 189.49 CHF | 09.04.2025 |
NAV * | 219.09 CHF | 26.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 5,119,595,486 | |
Unit/Share Assets *** | 194,206,542 | |
Trading Information SIX |
YTD Performance | +9.09% |
31.12.2024 - 26.08.2025
31.12.2024 26.08.2025 |
---|---|---|
1 month | +1.47% |
28.07.2025 - 26.08.2025
28.07.2025 26.08.2025 |
3 months | -0.36% |
26.05.2025 - 26.08.2025
26.05.2025 26.08.2025 |
6 months | -1.96% |
26.02.2025 - 26.08.2025
26.02.2025 26.08.2025 |
1 year | +2.93% |
26.08.2024 - 26.08.2025
26.08.2024 26.08.2025 |
2 years | +15.88% |
28.08.2023 - 26.08.2025
28.08.2023 26.08.2025 |
3 years | +19.26% |
26.08.2022 - 26.08.2025
26.08.2022 26.08.2025 |
5 years | +30.57% |
26.08.2020 - 26.08.2025
26.08.2020 26.08.2025 |
Equity Participation Rate in % | 99.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.68% | |
---|---|---|
Nestle SA | 11.57% | |
Roche Holding AG | 11.41% | |
UBS Group AG Registered Shares | 5.78% | |
ABB Ltd | 5.34% | |
Zurich Insurance Group AG | 5.15% | |
Compagnie Financiere Richemont SA Class A | 4.53% | |
Swiss Re AG | 2.72% | |
Lonza Group Ltd | 2.61% | |
Alcon Inc | 2.27% | |
Last data update | 31.07.2025 |
TER | 0.14% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.14% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |